European Soft Tissue Reinforcement and Regeneration (Allografts, Xenografts, and Alloplasts) Markets for 2015-2021

May 20, 2015, 17:05 ET from Research and Markets

DUBLIN, May 20, 2015 /PRNewswire/ --

Research and Markets ( has announced the addition of the "European Markets for Soft Tissue Reinforcement and Regeneration - 2015" report to their offering.

     (Logo: )

The European market for soft tissue reinforcement and regeneration differs substantially from the U.S. market; the European adoption rate of biologics is significantly lower than that of the United States. Since biologic matrices are often significantly more expensive than their synthetic counterparts in Europe, the low biologic adoption rate has a substantial negative impact on the soft tissue market as a whole. Due to the strictly evidence-based approach throughout Europe, the benefits of biologic products, such as expedited healing and reduced likelihoods of graft rejection, are not seen to outweigh their high costs.

The European market for soft tissue reinforcement and regeneration includes graft devices that are designed to reinforce and regenerate soft tissues. Soft tissues are defined as aggregations of similarly specialized cells which collectively function to connect, support or surround other structures and organs of the body. These tissues include tendons, ligaments, fascia, skin, fibrous tissues, fat, synovial membranes, muscles, nerves and blood vessels. Collagen, the most abundant protein in mammals, is one of the characteristic elements inside the extracellular matrix of soft tissue and, as such, plays a critical role in soft tissue repair.

Because soft tissue essentially makes up the majority of a person, and there are countless medical conditions associated with soft tissue problems, a select group of large markets related to soft tissue repair will be covered in this report, including breast reconstruction, hernia repair, dural repair, vaginal slings, skin repair, sports medicine and tendon reinforcement, and dental soft tissue regeneration. These indications were selected because they feature the use of synthetic mesh and biological matrices to reinforce and regenerate deficient areas.

There are three primary classes of soft tissue reinforcement and regeneration devices: allografts, xenografts, and alloplasts.

Key Topics Covered:

1. Executive Summary

2. Research Methodology

3. Europe Soft Tissue Reinforcement And Regeneration Market Overview 

4. Country Profiles

5. Procedure Numbers

6. Breast Reconstruction Market

7. Hernia Repair Market

8. Dural Repair Market

9. Vaginal Sling Market

10. Skin Repair Market

11. Sports Medicine And Tendon Reinforcement Market

12. Dental Soft Tissue Regeneration Market

13. Appendix I: Procedure Numbers

14. Appendix II: Breast Reconstruction Market

15. Appendix III: Hernia Repair Market

16. Appendix IV: Dural Repair Market

17. Appendix V: Vaginal Sling Market

18. Appendix VI: Skin Repair Market

19. Appendix VII: Sports Medicine And Tendon Reinforcement Market

20. Appendix VIII: Dental Soft Tissue Regeneration Market

21. Appendix IX: U.K. Pelvic Floor Reconstruction Market

22. Abbreviations

Companies Mentioned

- Aesculap/B.Braun
- American Medical Systems
- Baxter/Synovis
- Boston Scientific
- Botiss
- C.R. Bard
- Coloplast
- Cook Medical
- Covidien
- Depuy Synthes
- Ethicon
- Geistlich
- Integra LifeSciences
- LifeCell
- Lowmann & Rauscher
- Medskin Solutions
- Novus Scientific
- PFM Medical
- Serag-Wiessner
- Smith & Nephew
- Stryker
- Systagenix
- Tornier
- Tutogen

For more information visit

Media Contact: Laura Wood, +353-1-481-1716,

SOURCE Research and Markets